Skip to content

Progyny PGNY Accounts Receivable

Accounts Receivable at other companies

CVS Health logo
CVS HealthCVS
$40.99B+3.4%
UnitedHealth Group logo
UnitedHealth GroupUNH
$26.59B-1.3%
Natera, Inc. logo
Natera, Inc.NTRA
$417.6M+31.2%
Organon logo
OrganonOGN
$1.38B-5.0%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$61.31M+1,156%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$513.68M+32.1%

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's accounts receivable?
Progyny (PGNY) reported accounts receivable of $263.61M in Q1 2026.
How has Progyny's accounts receivable changed year-over-year?
Progyny's accounts receivable decreased by 12.1% year-over-year, from $299.74M to $263.61M.
What is the long-term trend for Progyny's accounts receivable?
Over 4 years (2021 to 2025), Progyny's accounts receivable has grown at a 18.6% compound annual growth rate (CAGR), from $527.17M to $1.04B.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.